{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2939, 
        2953
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3267, 
        3281
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3575, 
        3589
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4240, 
        4263
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2847, 
        2874
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        489, 
        518
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2351, 
        2386
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3483, 
        3506
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2920, 
        2928
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3176, 
        3182
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3248, 
        3256
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3556, 
        3564
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3736, 
        3742
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3808, 
        3814
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3879, 
        3885
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3994, 
        4000
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4065, 
        4071
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4138, 
        4144
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4210, 
        4216
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2929, 
        2938
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3183, 
        3199
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3257, 
        3266
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3565, 
        3574
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3743, 
        3759
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3815, 
        3831
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3886, 
        3895
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4001, 
        4017
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4072, 
        4088
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4145, 
        4161
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4217, 
        4233
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2896, 
        2906
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3153, 
        3163
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3225, 
        3234
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3408, 
        3417
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3532, 
        3542
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3713, 
        3723
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3785, 
        3794
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3857, 
        3866
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3972, 
        3980
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4044, 
        4052
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4115, 
        4124
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4188, 
        4197
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2876, 
        2877
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 11^9311^MOH|PIMS|CCO|20160502113216|A85A9D8A1D8B480AFF287A54FEE0F15AC36DC6DE|ORU^R01|99999999999999999999|P|2.5|||||\nPID|1||^^^^MRN^HOSPITAL 11&9999&MOH~9999999999&MC&ON^^^^JHN||XXXXXXX^XXXXXXXXXX^||99999999|M|||99 XXXXXXXXX XXXXX #9999^^XXXXXXX^XX^X9X9X9^999|||||||||||||||||||N|\nOBR|1||BZ00604430|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160421|||29978^XXXXXX^XXXX^^^XX.||||||||||||20160502|||F|||||||99999^XXXXXXX^XXXX^XXXXXX^^XX|\n\n\n\n\n\n\n\nPath report.gross description\n\n1.Specimen consists of 1 tan tissue corenE\\measuring 7 mm and 2 fragments measuring in totalnE\\6 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\2.Specimen consists of 1 tan tissue corenE\\measuring 23 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\3.Specimen consists of 1 tan tissue corenE\\measuring 15 mm and 1 fragment measuring in totalnE\\4 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\4.Specimen consists of 1 tan tissue corenE\\measuring 20 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\5.Specimen consists of 1 tan tissue corenE\\measuring 18 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\6.Specimen consists of 1 tan tissue corenE\\measuring 15 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\7.Specimen consists of 2 tan tissue coresnE\\measuring 9 and 11 mm and 1 fragment measuring innE\\total 1 mm in length by less than 1 mm innE\\diameter. Embedded in toto.nE\nE\\8.Specimen consists of 1 tan tissue corenE\\measuring 17 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\9.Specimen consists of 1 tan tissue corenE\\measuring 13 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\10.Specimen consists of 1 tan tissue corenE\\measuring 6 mm and 4 fragments measuring in totalnE\\12 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\11.Specimen consists of 1 tan tissue corenE\\measuring 15 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\12.Specimen consists of 2 tan tissue coresnE\\measuring 5 and 14 mm and 1 fragment measuring innE\\total 1 mm in length by less than 1 mm innE\\diameter. Embedded in toto.nE\\\n\n\nPath report.microscopic observation\n\nTumour TypenE\\Adenocarcinoma, conventional typenE\nE\\ExtentnE\\# sites involved/total sites  3 / 12nE\\# cores involved/total cores  3 / 12nE\\Overall % tissue involved  \\R\\4%nE\\% involvement in mostnE\\extensively involved core  30%nE\nE\\GleasonnE\\Overall Gleason Score (1?, worst)6 (3, 3)nE\\Highest Gleason Score (any site)6 (3, 3)nE\\OthernE\\% Gleason patterns 4, 5  0%nE\nE\\Perineural invasion     Not identifiednE\\Periprostatic fat invasion  Not identifiednE\\\n\n\nPath report.final diagnosis\n\n1.BIOPSY, PROSTATE (RIGHT BASE LATERAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 6/10 (PRIMARY 3, SECONDARY 3); 1 COREnE\\FRAGMENT INVOLVED; ABOUT 30% TISSUE INVOLVEMENT.nE\nE\\- FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIAnE\\(PIN), HIGH GRADE.nE\nE\\2.BIOPSY, PROSTATE (RIGHT BASE MEDIAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\3.BIOPSY, PROSTATE (RIGHT MID LATERAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 6/10 (PRIMARY 3, SECONDARY 3); 1/1 COREnE\\INVOLVED; LESS THAN 5% TISSUE INVOLVEMENT.nE\nE\\4.BIOPSY, PROSTATE (RIGHT MID MEDIAL)nE\\- FOCAL CHRONIC INFLAMMATION WITH GLANDULARnE\\ATROPHY, NEGATIVE FOR MALIGNANCY.nE\nE\\5.BIOPSY, PROSTATE (RIGHT APEX LATERAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 6/10 (PRIMARY 3, SECONDARY 3); 1/1 COREnE\\INVOLVED; ABOUT 15% TISSUE INVOLVEMENT.nE\nE\\6.BIOPSY, PROSTATE (RIGHT APEX MEDIAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\7.BIOPSY, PROSTATE (LEFT BASE LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\8.BIOPSY, PROSTATE (LEFT BASE MEDIAL)nE\\- BENIGN PROSTATIC AND SEMINALnE\\VESICLE/EJACULATORY DUCT-TYPE TISSUE.nE\nE\\9.BIOPSY, PROSTATE (LEFT MID LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\10.BIOPSY, PROSTATE (LEFT MID MEDIAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\11.BIOPSY, PROSTATE (LEFT APEX LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\12.BIOPSY, PROSTATE (LEFT APEX MEDIAL)nE\\- BENIGN PROSTATIC TISSUE.nE\\\n\n\nPath report.relevant Hx\n\nPSA Total: 3.47 ng/mLnE\\Ratio:  2.67nE\\5ARI Therapy (past 6 months): NonE\\DRE Findings:  Normal/BPH/T1nE\\Location: Right basenE\\Volume (cc):  40+nE\\TRUS Findings: 43 ccnE\nE\\Other: PPSA = 5.2nE\nE\\Date and Time Placed in Formalin (NBF):nE\\2016/04/20 @ 07:08 hoursnE\\\n\n\n"
}